Biotech

All Articles

Basilea scores $268M BARDA funding for antifungals, antibiotics

.Basilea Pharmaceutica's job building brand-new antifungals has obtained a notable boost from the un...

Capricor sells Europe civil liberties to late-stage DMD therapy for $35M

.Possessing presently scooped up the U.S. legal rights to Capricor Therapeutics' late-stage Duchenne...

FDA fragments adcomm for Applied's rare illness drug

.After pushing the choice meeting for Applied Therapies' metabolic disorder medication govorestat, t...

Novo inks $600M NanoVation offer to examine genetic drugs ex-liver

.Novo Nordisk is actually proceeding its push in to genetic medications, accepting to pay NanoVation...

Innovent hyperlinks cytokine to intestines cancer cells feedbacks

.Innovent Biologics has helped make the scenario that its own checkpoint inhibitor-cytokine blend pr...

Merck, Daiichi ADC strikes goal in period 3 bronchi cancer research

.A period 3 test of Daiichi Sankyo and Merck &amp Co.'s HER3-directed antibody-drug conjugate (ADC) ...

Rakovina deepens artificial intelligence focus with collab to pick cancer targets

.Five months after Rakovina Therapies turned toward expert system, the cancer-focused biotech has jo...

Ascendis' dwarfism medicine favorites in phase 3, intimidates BioMarin

.Ascendis Pharma has emerged as a prospective hazard to BioMarin's Voxzogo, reporting period 3 devel...

Despite ph. 3 overlook, Alkeus observes pathway ahead for eye health condition resource

.Though Alkeus Pharmaceuticals' oral eye health condition asset stopped working to substantially red...

Kairos goes social along with $6M IPO to money tests of cancer drug

.With a trio of biotechs hitting the Nasdaq on Friday, it was actually quick and easy to overlook a ...